2017
DOI: 10.3201/eid2304.161532
|View full text |Cite
|
Sign up to set email alerts
|

Transmission of Hepatitis A Virus through Combined Liver–Small Intestine–Pancreas Transplantation

Abstract: Vaccination of the donor might have prevented infection in the recipient and subsequent transmission to healthcare workers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 21 publications
1
16
0
Order By: Relevance
“…Therefore, the HAV vaccine should be given prior to kidney transplantation. Moreover, the HAV can be transmitted through organ transplantation and reactivate after liver transplantation [80,81].…”
Section: Viral Hepatitismentioning
confidence: 99%
“…Therefore, the HAV vaccine should be given prior to kidney transplantation. Moreover, the HAV can be transmitted through organ transplantation and reactivate after liver transplantation [80,81].…”
Section: Viral Hepatitismentioning
confidence: 99%
“…Half of the 1207 records classified under “harm to a recipient” were cases of infection transmission, involving organs (324/604), tissues (124/604), blood (108/604), HPCs (35/604), reproductive tissues and cells (9/604), and other (4/604). New pathogens have been added in the adverse occurrence type taxonomy in recent years: hepatitis A virus (first reported transmission of hepatitis A virus through multivisceral transplantation 12 ), Talaromyces (first reported case of presumptive donor-derived Talaromyces marneffei infection through bilateral lung transplantation 13 ), Borna virus (first report of donor-derived Borna disease virus 1 through kidneys and liver transplantation 14 ), and Japanese Encephalitis virus (first reported case of transfusion-transmitted Japanese Encephalitis virus 15 ). Cases of malignancy transmission included in the database account for 20.5% (247/1207) of the records, followed by immunological complications (205/1207; eg, ABO detrimental immunization or rejection in solid organ transplantation, acute or delayed hemolytic reactions after blood transfusion), miscellaneous complications (111/1207; eg, graft failure, dimethyl sulfoxide toxicity, undue exposure to risk or intervention, transfusion-associated circulatory overload), and noninfectious/nonmalignant transmissions (40/1207; eg, transmission of hypersensitivity or allergy by solid organ transplantation, transmission of alopecia areata or autoimmune thyroid disease following allogeneic bone marrow transplantation).…”
Section: Resultsmentioning
confidence: 99%
“…With only very rare exceptions, HAV infection causes only short-term, acute liver injury. Fecal shedding of virus and viremia (both detected by reverse transcription polymerase chain reaction [RT-PCR]) may be prolonged for months in infected neonates and severely immunocompromised liver transplant recipients (Rosenblum et al 1991;Foster et al 2017), but such reports are very rare in the literature. The replication of wild-type HAV does not cause cytopathic effects in vitro or in vivo (Daemer et al 1981;Binn et al 1984;Hirai-Yuki et al 2016a), and the disease is thought to be mediated by the host immune response to the virus (see Shin and Jeong 2018).…”
Section: Innate Immune Responses In Hepatitis Amentioning
confidence: 99%